Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options

J Jankowski, J Floege, D Fliser, M Böhm, N Marx - Circulation, 2021 - Am Heart Assoc
Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk
manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac …

Chemically and biologically engineered bacteria‐based delivery systems for emerging diagnosis and advanced therapy

Z Li, Y Wang, J Liu, P Rawding, J Bu… - Advanced …, 2021 - Wiley Online Library
Bacteria are one of the main groups of organisms, which dynamically and closely participate
in human health and disease development. With the integration of chemical biotechnology …

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

… Franssen Casper FM Hemmelder Marc H … - Nephrology Dialysis …, 2021 - academic.oup.com
Diabetes, hypertension and cardiovascular disease have been listed as risk factors for
severe coronavirus disease 2019 (COVID-19) since the first report of the disease in January …

Atherosclerosis in chronic kidney disease: more, less, or just different?

JM Valdivielso, D Rodríguez-Puyol… - … , and vascular biology, 2019 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

R Vanholder, L Annemans, E Brown… - Nature Reviews …, 2017 - nature.com
The treatment of chronic kidney disease (CKD) and of end-stage renal disease (ESRD)
imposes substantial societal costs. Expenditure is highest for renal replacement therapy …

FGF23 and klotho at the intersection of kidney and cardiovascular disease

D Edmonston, A Grabner, M Wolf - Nature Reviews Cardiology, 2024 - nature.com
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease
(CKD). As CKD progresses, CKD-specific risk factors, such as disordered mineral …

The heart and vascular system in dialysis

C Wanner, K Amann, T Shoji - The Lancet, 2016 - thelancet.com
The heart and the vascular tree undergo major structural and functional changes when
kidney function declines and renal replacement therapy is required. The many …

Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

A Amaya-Garrido, M Brunet, B Buffin-Meyer… - Science Translational …, 2023 - science.org
Vascular calcification is an important risk factor for cardiovascular (CV) mortality in patients
with chronic kidney disease (CKD). It is also a complex process involving …

Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review

E Harlacher, J Wollenhaupt, CC Baaten… - International journal of …, 2022 - mdpi.com
Patients with chronic kidney disease (CKD) are at a highly increased risk of cardiovascular
complications, with increased vascular inflammation, accelerated atherogenesis and …

Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis

J Pu, Z Jiang, W Wu, L Li, L Zhang, Y Li, Q Liu, S Ou - BMJ open, 2019 - bmjopen.bmj.com
Objective To assess the efficacy and safety of intradialytic exercise for haemodialysis
patients. Design Systematic review and meta-analysis. Data sources Databases, including …